1,585
Views
83
CrossRef citations to date
0
Altmetric
Articles

Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension

, &

References

  • Addis, E., Fleet, G. H., Cox, J. M. C., Kolak, D. and Leung, T. (2001). The growth, properties and interactions of yeasts and bacteria associated with the maturation of Camembert and blueveined cheeses. Int. J. Food Microbiol. 69:25–36.
  • Aihara, K., Kajimoto, O., Hirata, H., Takahashi, R. and Nakamura, Y. (2005). Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J. Am. College Nutr. 24:257–265.
  • Amirdivani, S. and Baba, S. A. (2011). Changes in yogurt fermentation characteristics, and antioxidant potential and in vitro inhibition of angiotensin-1 converting enzyme upon the inclusion of peppermint, dill and basil. LWT—Food Sci. Technol. 44:1458–1464.
  • Ao, X., Zhang, X., Zhang, X., Shi, L., Zhao, K., Yu, J., Dong, L., Cao, Y. and Cai, Y. (2012). Identification of lactic acid bacteria in traditional fermented yak milk and evaluation of their application in fermented milk products. J. Dairy Sci. 95:1073–1084.
  • Apostolidis, E., Kwon, Y. I. and Shetty, K. (2007). Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innovat. Food Sci. Emerg. Technol. 8:46–54.
  • Arai, S., Osawa, T., Ohigashi, H., Yoshikawa, M., Kaminogawa, S., Watanabe, M. et al. (2001). A mainstay of functional food science in Japan-history present status and future outlook. Biosci. Biotechnol. Biochem. 65:1–13.
  • Ardö, Y., Lilbaek, H., Kristiansen, K. R., Zakora, M. and Otte, J. (2007). Identification of large phosphopeptides from β-casein tahat characteristically accumulate during ripening of the semi-hard cheese Herrgard. Int. Dairy J. 17:513–524.
  • Ashar, M. N. and Chand, R. (2004a). Fermented milk containing ACE inhibitory peptides reduces blood pressure in middle aged hypertensive subjects. Milchwissenschaft. 59:363–366.
  • Ashar, M. N. and Chand, R. (2004b). Antihypertensive peptides purified from milks fermented with Lactobacillus delbrueckii spp. bulgaricus. Milchwissenschaft. 59:14–17.
  • Bai, M., Qing, M., Guo, Z., Zhang, Y., Chen, X., Bao, Q., Zhang, H. and Sun, T. S. (2010). Occurrence and dominance of yeast species in naturally fermented milk from the Tibetan Plateau of China. Canad. J. Microbiol. 56:707–714.
  • Benkerroum, N. (2010). Antimicrobial peptides generated from milk proteins: A survey and prospects for application in the food industry. Int. J. Dairy Technol. 63:320–338.
  • Bevilacqua, C., Helbling, J. C., Miranda, G., Martin, P., Jean, Christophe, H., Guy, M. and Patrice, M. (2006). Translational efficiency of casein transcripts in the mammary tissue of lactating ruminants. Reproduct. Nutr. Dev. 5:567–578.
  • Bhadoria, P. B. S. and Mahapatra, S. C. (2011). Prospects, technological aspects and limitaions of probiotic – A worldwide review. Eur. J. Food Res. Rev. 1:23–42.
  • Butikofer, U., Meyer, J., Sieber, R. and Wechsler, D. (2007). Quantification of the angiotensin-converting enzyme-inhibiting tripeptides Val Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses. Int. Dairy J. 17:968–975.
  • Chaves-López, C., Tofalo, R., Serio, A., Paparella, A., Sacchetti, G. and Suzzi, G. (2012). Yeasts from Colombian Kumis as source of peptides with Angiotensin I converting enzyme (ACE) inhibitory activity in milk. Int. J. Food Microbiol. 159:39–46.
  • Chaves-López, C., Serio, A. R., Paparella, A., Martuscelli, M., Corsetti, A., Tafalo, R. and Suzzi, G. (2014). Impact of microbial cultures on proteolysis and release of bioactive peptides in fermented milk. Food Microbiol. 42:117–121.
  • Chen, Y., Wang, Z., Chen, X., Liu, Y., Zhang, H. and Sun, T. (2010). Identification of angiotensin I-converting enzyme inhibitory peptides from koumiss, a traditional fermented mare's milk. J. Dairy Sci. 93:884–892.
  • Chen, Y., Liu, W., Xue, J., Yang, J., Chen, X., Shao, Y., Kwok, L., Bilige, M., Mang, L. and Zhang, H. (2014). Angiotensin-converting enzyme inhibitory activity of Lactobacillus helveticus strains from traditional fermented dairy foods and antihypertensive effect of fermented milk of strain H9. J. Dairy Sci. 10:2014–7962.
  • Chen, Y, Li, C., Xue, J., Kwok, L. Y., Yang, J., Zhang, H., Bilige, Menghe. (2015). Characterization of angiotensin-converting enzyme inhibitory activity of fermented milk produced by Lactobacillus helveticus. J. Dairy Sci. doi:10.3168/jds.2015-9382.
  • Choi, J., Sabiki, L., Hassan, A. and Anand, S. (2012). Bioactive peptides in Dairy products. Int. J. Dairy Technol. 65:1–12.
  • Cicero, A. F. G., Gerocarni, B., Laghi, L. and Borg, C. (2011). Blood pressure lowering effect of lactotripeptides assumed as functional foods: A meta-analysis of current available clinical trials. J. Human Hyperten. 25:425–436.
  • Corbo, M. R., Lanciotti, R., Albenzio, M. and Sinigaglia, M. (2001). Occurrence and characterization of yeasts isolated from milks and dairy products of Apulia region. Int. J. Food Microbiol. 69:147–152.
  • De Noni, I., FitzGerald, R. J., Korhonen, H. J. T., Le Roux, Y., Livesey, C. T., Thorsdottir, I., Tome, D. and Witcamp, R. (2009). Review of the potential health impact of β-casomorphin and related peptides. EFSA Sci. Report. 231:1–107.
  • Didelot, S., Bordenave-Juchereau, S., Rosenfeld, E., Piot, J. M. and Sannier, F. (2006). Peptides released from acid goat whey by a yeast-lactobacillus association isolated from cheese microflora. J. Dairy Res. 73:163–170.
  • Doggrell, S. A. and Brown, L. (1998). Rat models for hypertension, cardiac hypertrophy and failure. Cardiovascul. Res. 39:89–105.
  • Donkor, O. N., Henriksson, A., Singh, T. K., Vasiljevic, T. and Shah, N. P. (2007). ACE-inhibitory activity of probiotic yoghurt. Int. Dairy J. 17:1321–1331.
  • Exterkate, F. A. (1995). The lactococcal cell envelope proteinases: Differences, calcium-binding effects and role in cheese ripening. Int. Dairy J. 5:995–1018.
  • Fadda, M. E., Viale, S., Deplano, M., Pisano, M. B. and Cosentino, S. (2010). Characterization of yeast population and molecular fingerprinting of Candida zeylanoides isolated from goat's milk collected in Sardinia. Int. J. Food Microbiol. 136:376–380.
  • Farrell, H. M. Jr., Jimenez-Flores, R., Bleck, G. T., Brown, E. M., Butler, J. E., Creamer, L. K., Hicks, C. L., Hollar, C. M., Ng-Kwai-Hang, K. F. and Swaisgood, H. E. (2004). Nomenclature of the proteins of cows' milk-Sixth revision. J. Dairy Scis. 87:1641–1674.
  • Ferreira, S. H., Bartelt, D. C. and Greene, L. J. (1970). Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9:2583–2593.
  • FitzGerald, R. J., Murray, B. A. and Walsh, D. J. (2004). Hypotensive peptides from milk protein. J. Nutr. 34:9805–85.
  • Fleet, G. H. (2007). Yeasts in foods and beverages: Impact on product quality and safety. Curr. Opin. Biotechnol. 18:170–175.
  • Fujita, H., Yokoyama, K. and Yoshikawa, M. (2000). Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J. Food Sci. 65:564–569.
  • Fuchs, S., Frenzel, K., Hubert, C., Lyng, R., Muller, L., Michaud, A., et al. (2008). Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo. Hypertension. 51:267–274.
  • Galland, B. V., Cordova, A. F. G. and Figueroa, J. C. R. (2014). Lactococcus lactis strains for the production of bioactive peptides having antihypertensive and cholesterol lowering effects. US Patent No: US 20150064271 A1.
  • Ginger, M. R. and Grigor, M. R. (1999). Comparative aspects of milk caseins. Comparat. Biochem. Physiol. 124:133–145.
  • Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F. and Addeo, F. (2000). Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. Bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl. Environ. Microbiol. 66:3898–3904.
  • Gobbetti, M., Stepaniak, L., De Angelis, M., Corsetti, A. and Di Cagno, R. (2002). Latent bioactive peptides in milk proteins: Proteolytic activation and significance in dairy processing. Crit. Rev. Food Sci. Nutr. 42:223–239.
  • Gomez-Ruiz, J. A., Ramos, M. and Recio, I. (2002). Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. Int. Dairy J. 12:697–706.
  • Gomez-Ruiz, J. A., Ramos, M. and Recio, I. (2004). Identification and formation of angiotensin-converting enzyme-inhibitory peptides in Manchego cheese by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A. 1054:269–77.
  • Gomez-Ruiz, J. A., Taborda, G., Amigo, L., Recio, I. and Ramos, M. (2006). Identification of ACE-inhibitory peptides in different Spanish cheeses by tandem mass spectrometry. Eur. Food Res. Technol. 223:595–601.
  • Gonzalez-Gonzalez, C, Gibson, T. and Jauregi, P. (2013). Novel probiotic-fermented milk with angiotensin I-converting enzyme inhibitory peptides produced by Bifidobacterium bifidum MF 20/5. Int. J. Food Microbiol. 167:131–137.
  • Goodman, B. E. (2010). Insight into digestion and absorption of major nutrients in human. Adv. Physiol. Educat. 34:44–53.
  • Gútiez, L., Gómez-Sala, B., Recio, I., Del Campo, R., Cintas, L. M., Herranz, C. and Hernández, P. E. (2013). Enterococcus faecalis strains from food, environmental, and clinical origin produce ACE-inhibitory peptides and other bioactive peptides during growth in bovine skim milk. Int. J. Food Microbiol. 166:93–101.
  • Haandrikman, A. J., Meesters, R., Laan, H., Konings, W. N., Kok, J. and Venema, G. (1991). Processing of the lactococcal extracellular serine proteinase. Appl. Environ. Microbiol. 57:1899–1904.
  • Haque, E. and Chand, R. (2008). Antihypertensive and antimicrobial bioactive peptides from milk protein. Eur. Food Res. Technol. 227:7–15.
  • Hartmann, R. and Meisel, H. (2007). Food-derived peptides with biological activity: From research to food applications. Curr. Opin. Biotechnol. 18:163–169.
  • Hata, Y., Yamamoto, M., Ohni, H., Nakajima, K., Nakamura, Y. and Takano, T. (1996). A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 64:767–771.
  • Hayes, M., Poss, R. P., Fitzgerald, G. F., Hill, C. and Stanton, C. (2006). Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. Appl. Environ. Microbiol. 2260–2264.
  • Hayes, M., Stanton, C., Fitzgerald, G. F. and Ross, R. P. (2007). Putting microbes to work, Dairy fermentation, cell factories and bioactive peptides. Part II: Bioactive peptide functions. Biotechnol. J. 2:435–449.
  • He, R., Ma, H., Zhao, W., Qu, W., Zhao, J., Luo, L. and Zhu, W. (2012). Modeling the QSAR of ACE-Inhibitory peptides with ANN and its applied illustration. Int. J. Pept. 1–9.
  • Hernández-Ledesma, B., Amigo, L., Ramos, M. and Recio, I. (2004). Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. J. Agric. Food Chem. 52:1504–10.
  • Hernández-Ledesma, B., Miralles, B., Amigo, L., Ramos, M. and Recio, I. (2005). Identification of antioxidant and ACE-inhibitory peptides in fermented milk. J. Agric. Food Chem. 85:1041–1048.
  • IDFA. (2011). Dairy Facts. International Dairy foods Association, Washington, DC. Available from http://www.idfa.org/resource-center/industry-facts
  • Inoue, K., Shirai, T., Ochiai, H., Kasao, M. et al. (2003). Blood-pressure-lowering effect of a novel fermented milk containing gamma-butyric acid (GABA) in mild hypertensives. Eur. J. Clin. Nutr. 57:490–495.
  • Jauhiainen, T., Vapaatalo, H., Poussa, T., Kyrönpalo, S., Rasmussen, M. and Korpela, R. (2005). Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-hour ambulatory blood pressure measurement. Am. J. Hypertens. 18:1600–1605.
  • Jauhiainen, T., Wuolle, K., Vapaatalo, H., Kerojoki, O., Nurmela, K., Lowrie, C. and Korpela, R. (2007a). Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats. Int. Dairy J. 17:1216–1223.
  • Jauhiainen, T., Rönnback, M., Vapaatalo, H., Wuolle, K., Kautiainen, H. and Korpela, R. (2007b). Lactobacillus helveticus fermented milk reduces arterial stiffness in hypertensive subjects. Int. Dairy J. 17:1209–11.
  • Kajimoto, O., Kurosaki, T., Mizutani, J., Ikeda, N., Kaneko, K., Aihara, K., Yabune, M. and Nakamura, Y. (2002). Antihypertensive effects of liquid yogurts containing “lactotripeptides (VPP, IPP)” in mild hypertensive subjects. J. Nutr. Food. 5:55–66.
  • Kilpi, E. E. R., Kahala, M. M., Steele, J. L., Pihlanto, A. M. and Joutsjoki, V. V. (2007). Angiotensin I-converting enzyme inhibitory activity in milk fermented by wild-type and peptidase-deletion derivatives of Lactobacillus helveticus CNRZ32. Int. Dairy J. 17:976–984.
  • Korhonen, H. (2009). Milk-derived bioactive peptides: From science to applications. J. Funct. Foods. 1:177–187.
  • Korhonen, H. and Pihlanto, A. (2003). Food-derived bioactive peptides—opportunities for designing future foods. Curr. Pharm. Design. 9:1297–1308.
  • Kuipers, O. P. (2001). Complete DNA sequence of Lactococcus lactis adds flavor to genomics. Genome Res. 11:673–674.
  • LeBlanc, J. G., Matar, C., Valdéz, J. C., LeBlanc, J. and Perdigón, G. (2002). Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J. Dairy Sci. 85:2733–2742.
  • Li, Y., Sadiq, F. A., Liu, T. J., Chen, J. C. and He, G. Q. (2015). Purification and identification of novel peptides with inhibitory effect against angiotensin I-converting enzyme and optimization of process conditions in milk fermented with the yeast Kluyveromyces marxianus. J. Funct. Foods. 16:278–288.
  • Lignitto, L., Cavatorta, V., Balzan, S., Gabai, G., Galaverna, G., Novelli, E., Sforza, S. and Segato, S. (2010). Angiotensin-converting enzyme inhibitory activity of water-soluble extracts of Asiago d'allevo cheese. Int. Dairy J. 20:11–17.
  • Lim, S. M., Lee, N. K., Park, K. K., Yoon, Y. C. and Paik, H. D. (2011). ACE-inhibitory effect and physicochemical characteristics of yogurt beverage fortified with whey protein hydrolysates. Korean J. Food Sci. Animal Resources 31:886–892.
  • Lin, L., Lv, S. and Li, B. (2012). Angiotensin-I-converting enzyme (ACE)-inhibitory and antihypertensive properties of squid skin gelatin hydrolysates. Food Chem. 131:225–230.
  • Lunow, D., Kaiser, S., Rückriemen, J., Pohl, C. and Henle, T. (2015). Tryptophan-containing dipeptides are C-domain selective inhibitors of angiotensin converting enzyme. Food Chem. 166:596–602.
  • Madureira, A. R., Pereira, C. I., Gomes, A. M. P., Pintado, M. E. and Malcata, F. X. (2007). Bovine whey protein – overview on their main biological properties. Food Res. Int. 40:1197–1211.
  • Masuda, O., Nakamura, Y. and Takano, T. (1996). Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr. 126:3063–3068.
  • McCarron, D. A., Molly, E. and Reusser, B. A. (1999). Finding Consensus in the dietary Calcium-blood pressure debate. J. Am. College Nutr. 18:398S–405S.
  • Meira, S. M. M., Daroit, D. J., Helfer, V. E. et al. (2012). Bioactive peptides in water soluble extract of ovine cheese from southern Brazil and Uruguay. Food Res. Int. 48:322–329.
  • Meisel, H., Goepfert, A. and Günther, S. (1997). ACE inhibitory activities in milk products. Milchwissenschaft-Milk Sci. Int. 52:307–311.
  • Meyer, J., Butikofer, U., Walther, B., Wechsler, D. and Sieber, R. (2009). Hot topic: Changes in angiotensin-converting enzyme inhibition and concentration of the teripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties. J. Dairy Sci. 92:826–836.
  • Michaelidou, A., Alichanidis, E., Urlaub, H., Polychroniadou, A. and Zerfiridis, G. K. (1998). Isolation and identification of some major water-soluble peptides in Feta cheese. J. Dairy Sci. 81:3109–3116.
  • Miguel, M., Recio, I., Ramos, M., Delgado, M. A. and Aleixandre, M. A. (2006). Antihypertensive effect of peptides obtained from Enterococcus faecalis fermented milk in rats. J. Dairy Sci. 89:3352–9.
  • Miguel, M., Contreras, M. M., Recio, I. and Aleixandre, A. (2009). ACE-inhibitory and antihypertensive properties of a bovine casein hydrolysate. Food Chem. 112:211–214.
  • Minervini, F., Bilancia, M. T., Siragusa, S., Gobbetti, M. and Caponio, F. (2009). Fermented goats' milk produced with multiple starters as a potentially functional food. Food Microbiol. 26:559–564.
  • Moslehishad, M., Ehsani, M. R. and Salami, M. (2013). The comparative assessment of ACE- inhibitory and antioxidant activities of peptide fractions obtained from fermented camel and bovine milk by Lactobacillus rhamnosus PTCC1637. Int. Dairy Res. 29:82–87.
  • Mu, Z., Yang, X. and Yaun, H. (2012). Detection and identification of wild yeast in Koumiss. Food Microbiol. 31:301–308.
  • Muguerza, B., Ramos, M., Sanchez, E., Manso Miguel, M., Aleixandre, A., Degalo, M. A. and Recio, I. (2006). Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk. Int. Dairy Res. 16:61–69.
  • Nakamura, Y., Masuda, O. and Takano, T. (1996). Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 60:488–9.
  • Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S. and Takano, T. (1995a). Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 78:777–783.
  • Nakamura, Y., Yamamoto, N., Sakai, K., Takano, T. (1995b). Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J. Dairy Sci. 78:1253–1257.
  • Nandhini, B. and Palaniswamy, M. (2013). Anticancer effect of goat milk fermented by Lactobacillus plantarum and Lactobacillus paracasei. Int. J. Pharm. Pharm. Sci. 5:898–901.
  • Nejati, F., Rizzello, C. G., Cagno, R. D., Sheikh-Zeinoddin, M., Diviccaro, A., Minervini, F. and Gobbetti, M. (2013). Manufacture of a functional fermented milk enriched of Angiotensin-I Converting Enzyme (ACE)-inhibitory peptides and γ-amino butyric acid (GABA). LWT- Food Sci. Technol. 51:183–189.
  • Nilsen, R., Pripp, A. H., Høstmark, A. T., Haug, A. and Skeie, S. (2014). Short communication: Is consumption of a cheese rich in angiotensin-converting enzyme-inhibiting peptides, such as the Norwegian cheese Gamalost, associated with reduced blood pressure. J. Dairy Sci. 97:2662–2668.
  • Nielsen, M. S., Martinussen, T., Flambard, B., Sørensen, K. I. and Otte, J. (2009). Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: Effect of bacterial strain, fermentation pH, and storage time. Int. Dairy J. 19:155–165.
  • Okamoto, A., Hanagata, H., Matsumoto, E., Kawamura, Y., Koizumi, Y. and Yanagida, F. (1995). Angiotensin-converting enzyme inhibitory activities of various fermented foods. Biosci. Biotechnol. Biochem. 59:1147–1149.
  • Ong, L., Henriksson, A. and Shah, N. P. (2007). Angiotensin converting enzyme-inhibitory activity in Cheddar cheeses made with the addition of probiotic Lactobacillus casei sp. Lait. 87:149–165.
  • Ong, L. and Shah, N. P. (2008). Release and identification of angiotensin-converting enzyme-inhibitory peptides influenced by ripening temperatures and probiotic adjuncts in Cheddar cheeses. Lebenson Wiss Technol. 41:1555–1566.
  • Pachlová, V., Bunka, F., Flasarová, R., Válková, P. and ková, L. B. (2012). The effect of elevated temperature on ripening of Dutch type cheese. Food Chem. 132:1846–1854.
  • Padilla, B., Manzanares, P. and Belloch, C. (2014). Yeast species and genetic heterogeneity within Debaryomyces hansenii along the ripening process of traditional ewes and goats cheeses. Food Microbiol. 38:160–166.
  • Pan, D. and Guo, Y. (2010). Optimization of sour milk fermentation for the production of ACE-inhibitory peptides and purification of a novel peptide from whey protein hydrolysate. Int. Dairy J. 20:472–479.
  • Papadimitriou, C. G., Vafopoulou-Mastrojiannaki, A., Silva, S. V., Gomes, A. M., Malcata, F. X. and Alichanidis, E. (2007). Identification of peptides in traditional and probiotic sheep milk yoghurt with angiotensin I-converting enzyme (ACE)-inhibitory activity. Food Chem. 105:647–656.
  • Parrot, S., Degraeve, P., Curia, C. and Martial-Gros, A. (2003). In vitro study on digestion of peptides in Emmental cheese: Analytical evaluation and in fluence on angiotensin I converting enzyme inhibitory peptides. Nahrung-Food. 47:87–94.
  • Phelan, M. and Kerins, D. (2011). The potential role of milk derived peptides in cardiovascular deseases. Food Funct. 2:153–167.
  • Philanto, A., Virtanen, T. and Korhonen, H. (2010). Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk. Int. Dairy J. 20:3–10.
  • Prasanna, P. H. P., Grandison, A. S. D. and Charalampopoulos,  . (2014). Bifidobacteria in milk products: An overview of physiological and biochemical properties, exopolysaccharide production, selection criteria of milk products and health benefits. Food Res. Int. 55:247–262.
  • Pripp, A. H., Sorensen, R., Stepaniak, L. and Sorhaug, T. (2006). Relationship between proteolysis and angiotensin-I-converting enzyme inhibition in different cheeses. Lebensmittel Wissenschaft Technol. 39:677–683.
  • Quiros, A., Hernandez-Ledesma, B., Ramos, M., Amigo, L. and Recio, I. (2005). Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. J. Dairy Sci. 88:3480–3487.
  • Quiros, A., Ramos, M., Muguerza, B., Delgado, M., Miguel, M., Alexaindre, A. and Recio, I. (2007). Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. Int. Dairy J. 17:33–41.
  • Quiros, A., Contreras, M. M., Ramos, M., Amigo, L. and Recio, I. (2009). Stability to gastrointestinal enzymes and structure-activity relationship of β-casein-peptides with antihypertensive properties. Peptides. 30:1848–1853.
  • Qureshi, T. M., Vegarud, G. E., Abrahamensen, R. K. and Skeie, S. (2013). Angiotensin I converting enzyme inhibitory activity of Norwegian autochthonous cheeses Gamalost and Norvegia after in vitro human gastrointestinal digestion. J. Dairy Sci. 96:838–853.
  • Rai, A. K., Bhaskar, N., Prakash, M., Halami,  , Indirani, K., Suresh, P. V. and Mahendrakar, N. S. (2009). Characterization and application of a native lactic acid bacterium isolated from tannery fleshings for fermentative bioconversion of tannery fleshings. Appl. Microbiol. Biotechnol. 83:57–766.
  • Rai, A. K. and Jeyaram, K. (2015). Health benefits of functional proteins in fermented foods. In: Health Benefits of Fermented Foods and Beverages, pp. 455–474. Tamang, J. P., Eds. CRC Press, Taylor and Francis Group of USA.
  • Ramchandran, L. and Shah, N. P. (2008). Proteolytic profiles and Angiotensin-I converting enzyme and α-glucosidase inhibitory activities of selected lactic acid bacteria. J. Food Sci. 73:75–81.
  • Ramchandran, L. and Shah, N. P. (2011). Yogurt can beneficially affect blood contributors of cardiovascular health status in hypertensive rats. J. Food Sci. 76:H131–H136.
  • Rodriguez-Figueroa, J. C., Reyes-Díaz, R., González-Cordoba, A. F., Troncoso-Rojas, R., Vargas-Arispuro, I. and Vallejo-Cordoba, B. (2010). Angiotensin-converting enzyme inhibitory activity of milk fermented by wild and industrial Lactococcus lactis strains. J. Dairy Sci. 93:5032–5038.
  • Rodríguez-Figueroa, J. C., González-Córdova, A. F., Torres-Llanez, M. J., Garcia, H. S. and Vallejo-Cordoba, B. (2012). Novel angiotensin I-converting enzyme inhibitory peptides produced in fermented milk by specific wild Lactococcus lactis strains. J. Dairy Sci. 95:5536–43.
  • Rodríguez-Figueroa, J. C., González-Córdova, A. F., Astiazaran-García, H., Hernández-endoza, A. and Vallejo-Cordoba, B. (2013). Antihypertensive and hypolipidemic effect of milk fermented by specific Lactococcus lactis strains. J. Dairy Sci. 7:4094–4099.
  • Ryhänen, E. L., Pihlanto-Leppälä, A. and Pahkala, E. (2001). A new type of ripened, low-fat cheese with bioactive properties. Int. Dairy J. 11:441–447.
  • Sabeena, F. K. H., Baron, C. P., Nielsen, N. S. and Jacobsen, C. (2010). Antioxidant activity of yoghurt peptides:Part1-in vitro assays and evaluation in ω−3 enriched milk. Food Chem. 123:1081–1089.
  • Saito, Y., Wanezaki, K., Kawato, A. and Imayasu, S. (1994). Structure and activity of angiotensin I convertinf enzyme inhibitory peptides from sake and sake lees. Biosci. Biotechnol. Biochem. 58:1767–1771.
  • Saito, T., Nakamura, H., Kitazawa, H., Kawai, Y. and Itoh, T. (2000). Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J. Dairy Sci. 83:1434–1440.
  • Sanjukta, S., Rai, A. K., Ali, M. M., Jeyaram, K. and Talukdar, N. C. (2015). Enhancement of antioxidant properties of two soybean varieties of Sikkim Himalayan region by proteolytic Bacillus subtilis fermentation. J. Funct. Food. 14:650–658.
  • Schanbacher, F. L., Talhouk, R. S., Murray, F. A., Gherman, L. I. and Willet, L. B. (1998). Milk borne bioactive peptides. Int. Dairy J. 8:393–403.
  • Seppo, L., Kerojoki, O., Suomalainen, T. and Korpela, R. (2002). The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension: A pilot study on humans. Milchwissenschaft. 57:124–7.
  • Seppo, L., Jauhiainen, T., Poussa, T. and Korpela, R. (2003). A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Amer. J. Clin. Nutr. 77:326–30.
  • Settanni, L. and Moschetti, G. (2010). Non Starter lactic acid bacteria used to improve cheese quality and provide health benefits. Food Microbiol. 27:691–697.
  • Shori, A. B. and Baba, A. S. (2011). Antioxidant activity and inhibition of key enzymes linked to type-2 diabetes and hypertension by Azadirachta indica-yogurt. J. Saudi Chem. Soc. 17:295–301.
  • Sieber, R., Butikofer, U., Egger, C., Portmann, R., Walther, B. and Weschsler, D. (2010). ACE-inhibitory activity and ACE-inhibiting peptides in different cheese varieties. Dairy Sci. Technol. 90:47–73.
  • Singh, T. K., Fox, P. F. and Healy, A. (1997). Isolation and identification of further peptides in the diafiltration retentate of the water soluble fraction of Cheddar Cheese. J. Dairy Res. 64:433–443.
  • Sipola, M., Finckenberg, P., Korpela, R., Vapaatalo, H. and Nurminen, M. (2002). Effect of long-term intake of milk products on blood pressure in hypertensive rats. J. Dairy Res. 69:103–111.
  • Smacchi, E. and Gobbetti, M. (2000). Bioactive peptides in dairy products: Synthesis and interaction with proteolytic enzymes. Food Microbiol. 17:129–141.
  • Smacchi, E. and Gobbetti, M. (1998). Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme. Enzyme Microbiol. Technol. 22:687–694.
  • Solieri, L., Rutella, G. S. and Tagliazucchi, D. (2015). Impact of non-starter lactobacilli on release of peptides with angiotensin-converting enzyme inhibitory and antioxidant activities during bovine milk fermentation. Food Microbiol. 51:108–116.
  • Stanton, C., Gardiner, G., Meehan, H., Collins, K., Fitzgerald, G., Lynch, P. B. and Ross, R. P. (2001). Market potential for probiotics. Amer. J. Clin. Nutr. 73:476S–483S.
  • Taubert, D., Roesen, R. and Schomig, E. (2007). Effect of cocoa and tea intake on blood pressure: A meta-analysis. Arch. Int. Med. 167:626–634.
  • Tornadijo, M. E., Fresno, J. M., Martín Sarmiento, R. and Carballo, J. (1998). Study of the yeasts during the ripening process of Armada cheeses from raw goat's milk. Le Lait. 78:647–659.
  • Torres-Llanez, M. J., González-Córdova, A. F., Hernandez-Mendoza, A., Garcia, H. S. and Vallejo-Cordoba, B. (2011). Angiotensin-converting enzyme inhibitory activity in Mexican Fresco cheese. J. Dairy Sci. 94:3794–3800.
  • Urista, M. C., Fernandez, A. R., Rodriguez, R. F., Cuenca, A. A. and Jurado, T. A. (2011). Review: Production and functionality of active peptides from milk. Food Sci. Technol. Int. 17:293–317.
  • Vermeirssen, V., Camo, J. V. and Verrstraete, W. (2004). Bioavailibility of angiotensin I converting enzyme inhibitory peptides. British J. Nutr. 92:357–366.
  • Vinderola, G. (2008). Dried cell-free fraction of fermented milks: New functional additives for the food industry. Trend. Food Sci. Technol. 19:40–46.
  • Weimann, C., Meisel, H. and Erhardt, G. (2009). Short communication: Bovine κ-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides. J. Dairy Sci. 92:1885–1888.
  • Wijesekara, I., Qian, Z. J., Ryu, B., Ngo, D. H. and Kim, S. K. (2011). Purification and identification of antihypertensive peptides from seaweed pipefish (Syngnathus schlegeli) muscle protein hydrolysate. Food Res. Int. 44:703–707.
  • Xu, J. Y., Qin, L. Q., Wang, P. Y., Li, W. and Chang, C. (2008). Effect of milk tripeptides on blood pressure: A meta-analysis of randomized controlled trials. Nutrition. 24:933–940.
  • Yamamoto, N., Akino, A. and Takano, T. (1994). Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 77:917–922.
  • Yamamoto, N., Maeno, M. and Takano, T. (1999). Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci. 82:1388–1393.
  • Yamamoto, N. and Takano, T. (1999). Antihypetensive peptides derived from milk protein. Nahrung. 43:159–164.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.